| Trial ID: | L3876 |
| Source ID: | NCT04143412
|
| Associated Drug: |
Tritace (Ramipril 10 Mg)
|
| Title: |
Efficacy of ACE Inhibitors, MRAs and ACE Inhibitor/ MRA Combination
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetic Nephropathy Type 2|Microalbuminuria Due to Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Tritace (Ramipril 10 mg)
|
| Outcome Measures: |
Primary: Urinary albumin/creatinin ratio (UACR), Percentage change in albumin/creatinin ratio compared with the baseline value, 24 weeks | Secondary: Blood pressure, change in blood pressure level, 24 weeks|estimated Glomerular Filtration Rate (e GFR), change in estimated Glomerular Filtration Rate (e GFR), 24 weeks|Serum K, change in serum K level, 24 weeks
|
| Sponsor/Collaborators: |
Sponsor: Beni-Suef University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
75
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
|
| Start Date: |
2019-02-04
|
| Completion Date: |
2020-03
|
| Results First Posted: |
|
| Last Update Posted: |
2020-01-18
|
| Locations: |
Faculty of Medicine,Beni-Suef University, Banī Suwayf, 62511, Egypt
|
| URL: |
https://clinicaltrials.gov/show/NCT04143412
|
